Assessment of Palliative Care in Lung Cancer in Turkey
Autor: | Makbule Ozlem Akbay, Serdar Berk, Murat Acat, Durdu Mehmet Yavsan, Muharrem Erol, Uğur Yilmaz, Tevfik Özlü, Hüseyin Can, Gülay Cakmak, Talat Kilic, Yavuz Selim Intepe, Ayşe Senturk, Neslihan Özçelik, Gamze Kirkil, Sibel Ayik, Ilknur Basyigit, Hatice Selimoglu Sen, Hulya Gunbatar, Leyla Saglam, Berna Akinci Ozyurek, Ayse Dalli, Sibel Özkurt, Ozlem Oruc, Sibel Arınç, Sercan Erol, Selvi Asker, Yılmaz Bülbül, Fahrettin Talay, Zehra Yasar, Ahmet Emin Erbaycu, Perran Fulden Yumuk, Serap Argun Baris, Hidir Esme, Aysenur Bahadir, Yurdanur Erdoğan, Levent Cem Mutlu, Dursun Tatar, Ümran Toru, Arife Ulas, Mehmet Besiroglu, Turgut Teke, Melike Ozcelik, Buğra Kerget |
---|---|
Přispěvatelé: | BAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Yaşar, Zehra, Talay, Fahrettin, [Bulbul, Y. -- Ozlu, T. -- Ozcelik, N.] Karadeniz Tech Univ, Sch Med, Dept Chest Dis, Farabi Cd 66, TR-61080 Trabzon, Turkey -- [Gunbatar, H. -- Asker, S.] Yuzuncu Yil Univ, Sch Med, Dept Chest Dis, Van, Turkey -- [Saglam, L. -- Kerget, B.] Ataturk Univ, Sch Med, Dept Chest Dis, Erzurum, Turkey -- [Kilic, T.] Inonu Univ, Sch Med, Dept Chest Dis, Malatya, Turkey -- [Kirkil, G.] Firat Univ, Sch Med, Dept Chest Dis, Elazig, Turkey -- [Baris, S. A. -- Basyigit, I.] Kocaeli Univ, Sch Med, Dept Chest Dis, Kocaeli, Turkey -- [Yavsan, D. M. -- Teke, T.] Necmettin Erbakan Univ, Sch Med, Dept Chest Dis, Konya, Turkey -- [Sen, H. S.] Dicle Univ, Sch Med, Dept Chest Dis, Diyarbakir, Turkey -- [Berk, S.] Cumhuriyet Univ, Sch Med, Dept Chest Dis, Sivas, Turkey -- [Acat, M.] Karabuk Univ, Sch Med, Dept Chest Dis, Karabuk, Turkey -- [Intepe, Y. S.] Bozok Univ, Sch Med, Dept Chest Dis, Yozgat, Turkey -- [Toru, U.] Dumlupinar Univ, Sch Med, Dept Chest Dis, Kutahya, Turkey -- [Ayik, S. O. -- Dalli, A.] Katip Celebi Univ, Sch Med, Dept Chest Dis, Izmir, Turkey -- [Ozkurt, S.] Pamukkale Univ, Sch Med, Dept Chest Dis, Denizli, Turkey -- [Mutlu, L. C.] Namik Kemal Univ, Sch Med, Dept Chest Dis, Tekirdag, Turkey -- [Yasar, Z. A. -- Talay, F.] Abant Izzet Baysal Univ, Sch Med, Dept Chest Dis, Bolu, Turkey -- [Arinc, S. -- Akbay, M. O. -- Oruc, O.] Pulm Dis & Thorac Surg Educ & Res Hosp Sureyyapas, Istanbul, Turkey -- [Ozyurek, B. A. -- Erdogan, Y.] Pulm Dis & Thorac Surg Educ & Res Hosp Ataturk, Ankara, Turkey -- [Bahadir, A.] Pulm Dis & Thorac Surg Educ & Res Hosp Yedikule, Istanbul, Turkey -- [Yilmaz, U. -- Tatar, D. -- Erol, S. -- Erbaycu, A. E.] Pulm Dis & Thorac Surg Educ & Res Hosp Dr Suat Se, Izmir, Turkey -- [Senturk, A. -- Ulas, A.] Educ & Res Hosp Ataturk, Ankara, Turkey -- [Ozcelik, M.] Educ & Res Hosp Kartal, Istanbul, Turkey -- [Cakmak, G.] Educ & Res Hosp Haseki, Istanbul, Turkey -- [Esme, H.] Educ & Res Hosp Konya, Konya, Turkey -- [Yumuk, P. F. -- Besiroglu, M.] Marmara Univ, Dept Med Oncol, Sch Med, Istanbul, Turkey -- [Erol, M. M.] Uludag Univ, Dept Thorac Surg, Sch Med, Bursa, Turkey -- [Can, H.] Katip Celebi Univ, Dept Family Med, Sch Med, Izmir, Turkey, Acat, Murat -- 0000-0002-7163-4882, Erol, Serhat -- 0000-0003-1645-7761, intepe, yavuz selim -- 0000-0002-5697-5291, Yumuk, Perran Fulden -- 0000-0001-8650-299X, Kerget, Bugra -- 0000-0002-6048-1462, Bulbul, Yilmaz -- 0000-0002-8488-3650, Bulbul, Y., Ozlu, T., Arinc, S., Ozyurek, B. A., Gunbatar, H., Senturk, A., Bahadir, A., Ozcelik, M., Yilmaz, U., Akbay, M. O., Saglam, L., Kilic, T., Kirkil, G., Ozcelik, N., Tatar, D., Baris, S. A., Yavsan, D. M., Sen, H. S., Berk, S., Acat, M., Cakmak, G., Yumuk, P. F., Intepe, Y. S., Toru, U., Ayik, S. O., Basyigit, I., Ozkurt, S., Mutlu, L. C., Yasar, Z. A., Esme, H., Erol, M. M., Oruc, O., Erdogan, Y., Asker, S., Ulas, A., Erol, S., Kerget, B., Erbaycu, A. E., Teke, T., Besiroglu, M., Can, H., Dalli, A., Talay, F. |
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: |
squamous cell carcinoma
Male cancer pain Lung Neoplasms Turkey Palliative treatment oxygen therapy Comorbidity fentanyl Lung cancer Palliation Symptoms Treatment 0302 clinical medicine middle aged antidepressant agent bisphosphonic acid derivative comparative study Edmonton Symptom Assessment Scale adult Palliative Care vitamin morphine General Medicine cyproheptadine nausea aged Impact 030220 oncology & carcinogenesis depression disease severity prospective study cancer fatigue medicine.medical_specialty palliative therapy Nausea nutritional support complication percutaneous endoscopic gastrostomy Article 03 medical and health sciences Humans human Neoplasms Squamous Cell SLEEP DISTURBANCES noninvasive ventilation interview drowsiness dyspnea medicine.disease sedative agent major clinical study Logistic Models Parenteral nutrition quality of life pleurodesis cancer patient Palliative care IMPACT paracetamol dysphagia Turkey (republic) appetite stimulant wellbeing Quality of life QUALITY-OF-LIFE nonsteroid antiinflammatory agent Prevalence anxiety disorder pain 030212 general & internal medicine Fatigue Depression (differential diagnoses) bone metastasis sleep disorder Analgesics analgesia analgesic agent cancer palliative therapy CHEMOTHERAPY PREVALENCE female Anxiety pain severity SYMPTOM EXPERIENCE medicine.symptom bronchodilating agent nasogastric tube tramadol combination drug therapy anxiolytic agent nebulizer Pain parenteral nutrition psychology cachexia psychopharmacotherapy Interviews as Topic Quality-Of-Life Internal medicine SUPPORTIVE CARE medicine cancer radiotherapy Chemotherapy controlled study Neoplasm Staging loss of appetite thoracocentesis Original Paper symptom assessment business.industry cancer staging statistical model Symptom Experience megestrol acetate vitamin supplementation Supportive Care Physical therapy stent business Sleep Disturbances |
Zdroj: | Medical Principles and Practice |
Popis: | WOS: 000391457100008 PubMed ID: 27780164 Objective: To investigate the symptoms of lung cancer in Turkey and to evaluate approaches to alleviate these symptoms. Subjects and Methods: This study included 1,245 lung cancer patients from 26 centers in Turkey. Demographic characteristics as well as information regarding the disease and treatments were obtained from medical records and patient interviews. Symptoms were evaluated using the Edmonton Symptom Assessment Scale (ESAS) and were graded on a scale between 0 and 10 points. Data were compared using the. 2, Student t, and Mann-Whitney U tests. Potential predictors of symptoms were analyzed using logistic regression analysis. Results: The most common symptom was tiredness (n = 1,002; 82.1%), followed by dyspnea (n = 845; 69.3%), appetite loss (n = 801; 65.7%), pain (n = 798; 65.4%), drowsiness (n = 742; 60.8%), anxiety (n = 704; 57.7%), depression (n = 623; 51.1%), and nausea (n = 557; 45.5%). Of the 1,245 patients, 590 (48.4%) had difficulty in initiating or maintaining sleep. The symptoms were more severe in stages III and IV. Logistic regression analysis indicated a clear association between demographic characteristics and symptom distress, as well as between symptom distress (except nausea) and well-being. Overall, 804 (65.4%) patients used analgesics, 630 (51.5%) received treatment for dyspnea, 242 (19.8%) used enteral/parenteral nutrition, 132 (10.8%) used appetite stimulants, and 129 (10.6%) used anxiolytics/antidepressants. Of the 799 patients who received analgesics, 173 (21.7%) reported that their symptoms were under control, and also those on other various treatment modalities (dyspnea: 78/627 [12.4%], appetite stimulant: 25/132 [18.9%], and anxiolytics/antidepressants: 25/129 [19.4%]) reported that their symptoms were controlled. Conclusion: In this study, the symptoms progressed and became more severe in the advanced stages of lung cancer, and palliative treatment was insufficient in most of the patients in Turkey. (C) 2016 S. Karger AG, Basel |
Databáze: | OpenAIRE |
Externí odkaz: |